Page last updated: 2024-08-17

medroxyprogesterone acetate and Thrombophilia

medroxyprogesterone acetate has been researched along with Thrombophilia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blondon, M; Heckbert, SR; McKnight, B; Psaty, BM; Rice, KM; Smith, NL; Van Hylckama Vlieg, A; Wiggins, KL1
Chiba, K; Hosokawa, M; Kobayashi, K; Mimura, N; Nakamura, Y; Shimada, N1
Cicinelli, E; De Mitrio, V; Galantino, P; Giannoccaro, F; Marino, R1
Aisaka, K; Kaibara, M; Liang, SG; Okinaga, S; Ooka, F; Watanabe, T1

Other Studies

4 other study(ies) available for medroxyprogesterone acetate and Thrombophilia

ArticleYear
Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study.
    British journal of haematology, 2013, Volume: 163, Issue:3

    Topics: Aged; Case-Control Studies; Estrogens, Conjugated (USP); Estrogens, Esterified (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Models, Cardiovascular; Postmenopause; Risk; Smoking; Thrombophilia; Venous Thrombosis; Washington

2013
Metabolism of medroxyprogesterone acetate (MPA) via CYP enzymes in vitro and effect of MPA on bleeding time in female rats in dependence on CYP activity in vivo.
    Life sciences, 2003, Nov-07, Volume: 73, Issue:25

    Topics: Animals; Bleeding Time; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Isoenzymes; Male; Medroxyprogesterone Acetate; Microsomes, Liver; Phenobarbital; Proadifen; Rats; Rats, Wistar; Recombinant Proteins; Thrombophilia

2003
Improved sensitivity to activated protein C following postmenopausal hormone replacement therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1998, Volume: 9, Issue:3

    Topics: Administration, Cutaneous; Adult; Aged; Blood Coagulation; Disease Susceptibility; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Factor V; Factor VIII; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Postmenopause; Protein C; Protein S; Thrombophilia

1998
Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Clinical hemorheology and microcirculation, 2001, Volume: 24, Issue:2

    Topics: Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Antithrombin III; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Combined Modality Therapy; Endometrial Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematocrit; Hemostasis; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Peptide Hydrolases; Platelet Count; Risk; Thrombophilia

2001